New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 23, 2013
15:54 EDTDHR, JNJ, BX, CGCarlyle in lead to buy J&J ortho clinical diagnostics unit, Reuters says
Johnson & Johnson (JNJ) currently views a bid from Carlyle Group (CG) for its ortho clinical diagnostics unit as superior to a rival bid from Blackstone Group (BX) in partnership with conglomerate Danaher (DHR), three people familiar with the matter said, according to Reuters, which added that the price of Carlyle's offer could not be learned. Reference Link
News For JNJ;CG;BX;DHR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
November 19, 2014
09:04 EDTJNJJohnson & Johnson submits NDA for three-month paliperidone palmitate
Janssen Research & Development, a Johnson & Johnson company, announced the submission of a New Drug Application, or NDA, for three-month atypical antipsychotic paliperidone palmitate to the FDA. The NDA seeks approval for the medication as a treatment for schizophrenia in adults. If approved, it will be the first and only long-acting atypical antipsychotic that has a four times a year dosing schedule.
08:03 EDTDHRDanaher price target raised to $88 from $82 at Morgan Stanley
Subscribe for More Information
07:37 EDTCGCitigroup to hold a conference
Global Financial Conference is being held in Singapore on November 19-20.
06:46 EDTBXBlackstone planning conservative fund with long time horizon, Reuters says
Blackstone is looking to launch a new investment vehicle that would last for more than ten years and invest in slower growing, safer companies than most private equity funds, according to Reuters, which cited multiple unnamed sources. The fund would also use less debt and charge lower fees, the news service added. Reference Link
06:38 EDTBXBlackstone to buy Orica's Chemicals business for A$750M
Subscribe for More Information
06:30 EDTJNJJohnson & Johnson, Boston Scientific trial set to start tomorrow, Reuters says
Subscribe for More Information
November 18, 2014
07:56 EDTBXColumbia Management announces strategic initiative with BAAM
Subscribe for More Information
06:37 EDTBXBlackstone to sell 1095 Ave. of the Americas for $2.25B, WSJ reports
Blackstone Group will Manhattan office tower for about $2.25B to a venture led by Canadian property investor Ivanhoe Cambridge, the Wall Street Journal reports, citing sources. If completed, the sale of the 1.2M square-foot tower at 1095 Ave. of the Americas would be the second most expensive sale of an individual building in U.S. history, the WSJ says. Reference Link
November 17, 2014
07:16 EDTJNJMilken Institute--Faster Cures to hold a conference
Subscribe for More Information
November 14, 2014
16:21 EDTJNJOn The Fly: Closing Wrap
Subscribe for More Information
14:53 EDTJNJCVS Express Scripts implementing drug price controls, says Cleveland Research
Cleveland Research believes that CVS (CVS) and Express scripts are implementing rebates and price controls on drug. The firm expects the companies to increase their focus on controlling durg prices next year, and adds that they have already itnroduced prior authorization criteria for hepatitis drug. Publicly traded drug companies include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY). Makers of hepatits c drugs include AbbVie (ABBV) and Gilead (GILD),
08:15 EDTBXBlackstone may urge U.S. probe to speed sale of Waldorf, NY Post says
Subscribe for More Information
November 13, 2014
16:28 EDTJNJGeron announces global strategic collaboration with Janssen Biotech
Geron (GERN) announced that the company has entered into an exclusive worldwide license and collaboration agreement with Janssen Biotech, a Johnson & Johnson (JNJ) company, to develop and commercialize, imetelstat, Geron's telomerase inhibitor product candidate, for oncology, including hematologic malignancies, and other human therapeutics uses. Imetelstat is a modified oligonucleotide that is currently in early phase clinical development for myelofibrosis, or MF, and may have activity in other hematologic myeloid malignancies such as myelodysplastic syndrome, or MDS, and acute myelogenous leukemia, or AML. Under the terms of the agreement, Geron will receive an initial payment of $35M due after the applicable waiting periods under the Hart-Scott Rodino Act and is eligible to receive additional payments up to a potential total of $900M for the achievement of development, regulatory and commercial milestones, as well as royalties on worldwide net sales. Certain regulatory, development, manufacturing and promotional activities will be managed through a joint governance structure, with Janssen responsible for operational implementation of these activities. All sales will be booked by Janssen.
11:54 EDTJNJJanssen announces FDA approved sNDA for INVEGA SUSTENNA
Subscribe for More Information
10:44 EDTJNJMallinckrodt news on generic Concerta positive for Actavis, says BMO Capital
Subscribe for More Information
06:08 EDTBXBlackstone implied volatility of 22 at lower end of index mean range
Subscribe for More Information
November 12, 2014
13:54 EDTCGCarlyle Group interested in Serco units for sale, Sky News reports
Subscribe for More Information
10:00 EDTDHROn The Fly: Analyst Upgrade Summary
Subscribe for More Information
07:28 EDTCGBofA/Merrill to hold a conference
Subscribe for More Information
05:42 EDTDHRDanaher upgraded to Outperform from Market Perform at FBR Capital
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use